产品研发
RESEARCH

Novel Affinity Ligands- nanoselect

    Nanobody and Affibody are new novel affinity ligands, NBbiolab development a series of  unique affinity purification solution based on Camelid&shark-derived single domain antibody fragments(~15KD) and Affibody(6。5KD)。 These small affinity ligands, are the platform solution for any biopharmaceutical purification challenge and have been proven for many applications to result in a higher yield and an increased purity of the biopharmaceutical, as well as a reduction in the number of purification steps which all affect the cost of goods of the biopharmaceutical。 In addition, nanoselect  ligands can be tailored to protect the biopharmaceutical by mild elution conditions。 The manufacturing in yeast and Ecoli, without animal derived components, results in a high quality product without toxins and viruses。




Copyright ©2017 成都阿帕克生物科技有限公司 蜀ICP备17007098号-1    
地址:成都温江区青啤大道319号10幢2单元5楼 电话:400-166-9953 13551086942 邮箱:service@nb-biolab.com
24小时服务热线
400-166-9953
快乐时时彩 幸运飞艇怎么样 幸运飞艇pk10好玩吗 北京pk10怎样玩可以赢钱 幸运飞艇如何分析 幸运飞艇怎么样稳赚 幸运飞艇如何购买 快乐时时彩 幸运飞艇怎么玩容易中 幸运飞艇怎样压注稳赢